Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma by Esme Needham | Jan 21, 2026 | News | 0 More than 71% of patients treated with Unloxcyt achieved disease control Read More
US green lights new biologic for psoriasis by Selina McKee | Mar 22, 2018 | News | 0 The US Food and Drug Administration has approved Sun Pharma’s Ilumya as a new treatment option for adults with moderate-to-severe plaque psoriasis. Read More